Autolus Therapeutics PLC (NAS:AUTL)
$ 3.8598 0.0198 (0.52%) Market Cap: 1.03 Bil Enterprise Value: 314.33 Mil PE Ratio: 0 PB Ratio: 1.76 GF Score: 55/100

Autolus Therapeutics PLC at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 13, 2021 / 02:10PM GMT
Release Date Price: $8.81 (-1.78%)
Eric William Joseph
JPMorgan Chase & Co, Research Division - VP & Senior Analyst

Okay. Good morning, and thanks again for joining us at the JPMorgan Healthcare Conference. I'm Eric Joseph, senior biotech analyst. Our next presenting company this morning is Autolus, and it's my pleasure to welcome CEO, Christian Itin, to tell us a little bit about the company.

(Operator Instructions)

With that, Christian, thanks again for sharing some of your time with us.

Christian Martin Itin
Autolus Therapeutics plc - Chairman & CEO

Well, thank you very much for having us. And to be included in this year's presentation at the conference. Welcome, everybody. We'd like to first actually go on Slide 2. Please remember, have a look at our SEC filings, periodic filings, risk factors, look at our forward-looking statements in there, et cetera. And make sure that you're adequately informed.

So with that, I'd like to move to our lead programs and go to Slide #4. And obviously, we're focusing on our AUTO1 program in a disease setting in

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot